Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
 
 
Email
mdccwj@nus.edu.sg
 
 

Publications

Refined By:
Subject:  metabolism

Results 1-13 of 13 (Search time: 0.022 seconds).

Issue DateTitleAuthor(s)
12018A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseZhou, J ; Toh, S.H.-M; Chan, Z.-L; Quah, J.Y; Chooi, J.-Y ; Tan, T.Z ; Chong, P.S.Y ; Zeng, Q ; Chng, W.-J 
22016Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomasHirpara, J.L ; Loh, T ; Ng, S.B ; Chng, W.J ; Pervaiz, S 
3Jul-2017Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaKong, L.R ; Tan, T.Z ; Ong, W.R; Bi, C; Huynh, H ; Lee, S.C ; Chng, W.J ; Eichhorn, P.J.A ; Goh, B.C 
42016Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitorsFranke, N.E; Kaspers, G.L; Assaraf, Y.G; Meerloo, J; Niewerth, D; Kessler, F.L; Poddighe, P.J; Kole, J; Smeets, S.J; Ylstra, B; Bi, C; Chng, W.J ; Horton, T.M; Menezes, R.X; Musters, R.J.P; Zweegman, S; Jansen, G; Cloos, J
52015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
62017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
72018Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensRassidakis, G.Z; Herold, N; Myrberg, I.H; Tsesmetzis, N; Rudd, S.G; Henter, J.-I; Schaller, T; Ng, S.-B ; Chng, W.J ; Yan, B; Ng, C.H ; Ravandi, F; Andreeff, M; Kantarjian, H.M; Medeiros, L.J; Xagoraris, I; Khoury, J.D
81-Apr-2022Metabolic Vulnerabilities in Multiple MyelomaLim, Julia SL ; Chong, Phyllis SY ; Chng, Wee-Joo 
92016PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationTeoh P.J. ; Bi C.; Sintosebastian C.; Tay L.S. ; Fonseca R.; Chng W.J. 
102015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
112014Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsNg, S.-B ; Ohshima, K; Selvarajan, V ; Huang, G; Choo, S.-N; Miyoshi, H; Wang, S ; Chua, H.-C ; Yeoh, A.E.-J ; Quah, T.-C ; Koh, L.-P ; Tan, P.-L ; Chng, W.-J 
122016The emerging roles of exosomes in leukemogeneisZhou, J ; Wang, S; Sun, K; Chng, W.-J 
132014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G